NO993825D0 - Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler - Google Patents

Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler

Info

Publication number
NO993825D0
NO993825D0 NO993825A NO993825A NO993825D0 NO 993825 D0 NO993825 D0 NO 993825D0 NO 993825 A NO993825 A NO 993825A NO 993825 A NO993825 A NO 993825A NO 993825 D0 NO993825 D0 NO 993825D0
Authority
NO
Norway
Prior art keywords
nucleic acid
formulation
acid particles
transfection agents
cationic transfection
Prior art date
Application number
NO993825A
Other languages
English (en)
Other versions
NO993825L (no
Inventor
Joul Crouzet
Bruno Pitard
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO993825(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO993825L publication Critical patent/NO993825L/no
Publication of NO993825D0 publication Critical patent/NO993825D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
NO993825A 1997-02-10 1999-08-09 Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler NO993825D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (fr) 1997-02-10 1997-02-10 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
PCT/FR1998/000222 WO1998034648A1 (fr) 1997-02-10 1998-02-06 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees

Publications (2)

Publication Number Publication Date
NO993825L NO993825L (no) 1999-08-09
NO993825D0 true NO993825D0 (no) 1999-08-09

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993825A NO993825D0 (no) 1997-02-10 1999-08-09 Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler

Country Status (20)

Country Link
EP (1) EP1007097B1 (no)
JP (1) JP2001511171A (no)
KR (1) KR20000070914A (no)
AT (1) ATE206932T1 (no)
AU (1) AU737720B2 (no)
BR (1) BR9807563A (no)
CA (1) CA2278665A1 (no)
CZ (1) CZ282199A3 (no)
DE (1) DE69802102T2 (no)
DK (1) DK1007097T3 (no)
ES (1) ES2166146T3 (no)
FR (1) FR2759298B1 (no)
GR (1) GR3036919T3 (no)
HU (1) HUP0001720A3 (no)
IL (1) IL130765A0 (no)
NO (1) NO993825D0 (no)
PT (1) PT1007097E (no)
SK (1) SK282685B6 (no)
WO (1) WO1998034648A1 (no)
ZA (1) ZA981034B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
WO1999052858A2 (en) * 1998-04-08 1999-10-21 Celltech Therapeutics Limited Lipids
CA2335393C (en) * 1998-07-20 2008-09-23 Inex Pharmaceuticals Corporation Liposomal encapsulated nucleic acid-complexes
BR0108959A (pt) * 2000-03-03 2003-10-14 Valentis Inc Composições de polox‰mero ou poloxamina melhoradas para distribuição de ácido nucléico
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
CN1531422A (zh) * 2000-10-20 2004-09-22 治疗局部缺血的基因转移配方及方法
EP1232758A1 (fr) * 2001-02-19 2002-08-21 Aventis Pasteur Polynucléotide formulé en vue d'un transfert intracellulaire amélioré
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
EP1734984A4 (en) 2004-03-03 2009-07-29 Revance Therapeutics Inc COMPOSITIONS AND METHODS FOR TOPICAL DIAGNOSIS AND THERAPEUTIC TRANSPORT
RU2007136616A (ru) 2005-03-03 2009-04-10 Риванс Терапьютикс, Инк. (Us) Композиция и способ для местного применения и чрескожного введения ботулинового токсина
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (en) * 1994-08-09 2004-02-04 Cytrx Corporation Novel vaccine adjuvant and vaccine
WO1996030051A1 (en) * 1995-03-31 1996-10-03 Genetic Therapy, Inc. Use of surfactants for introducing genetic material into lung cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
DE69802102T2 (de) 2002-03-14
BR9807563A (pt) 2000-02-01
FR2759298A1 (fr) 1998-08-14
NO993825L (no) 1999-08-09
WO1998034648A1 (fr) 1998-08-13
IL130765A0 (en) 2001-01-28
FR2759298B1 (fr) 1999-04-09
GR3036919T3 (en) 2002-01-31
AU737720B2 (en) 2001-08-30
SK108299A3 (en) 2000-05-16
ZA981034B (en) 1998-08-11
ES2166146T3 (es) 2002-04-01
CA2278665A1 (fr) 1998-08-13
SK282685B6 (sk) 2002-11-06
PT1007097E (pt) 2002-04-29
HUP0001720A1 (hu) 2000-09-28
AU6298798A (en) 1998-08-26
EP1007097B1 (fr) 2001-10-17
CZ282199A3 (cs) 1999-10-13
HUP0001720A3 (en) 2001-10-29
JP2001511171A (ja) 2001-08-07
ATE206932T1 (de) 2001-11-15
DK1007097T3 (da) 2002-02-11
KR20000070914A (ko) 2000-11-25
DE69802102D1 (de) 2001-11-22
EP1007097A1 (fr) 2000-06-14

Similar Documents

Publication Publication Date Title
NO993825L (no) Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler
HK1017995A1 (en) Compounds and compositions for delivering active agents.
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
EP0911039A3 (en) Drug-resin complexes stabilized by chelating agents
PT1123120E (pt) Formulacao medicinal em aerossol
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
TR199500299A2 (tr) Farmasötik bilesimler.
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
WO2000032186A3 (en) Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
WO2000050046A8 (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
MXPA04001007A (es) Emulsion inversa que contiene dihidroepiandrosterona.
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
BR9811985A (pt) Dispositivo de dosagem
EP1385948A4 (en) NUCLEIC ACIDS FOR INHIBITING THE EXPRESSION OF HAIRLESS PROTEIN AND METHOD FOR USE THEREOF
TNSN97173A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant.
PH11997055419B1 (en) Cleansing composition comprising color stabilizer(s) and surfactant(s)
WO2000021577A3 (en) Compositions
HUP0202378A3 (en) Surfactant mixture, emulsion containing thereof structured surfactant composition and detergent composition
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid
Kamioka Dynamics and kinetics of oxidation of semiconductor surfaces
MX9603741A (es) Composicion de liberacion mantenida.
MY152490A (en) New oral formulation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application